These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36685833)

  • 21. High Matrix Metalloproteinase 28 Expression is Associated with Poor Prognosis in Pancreatic Adenocarcinoma.
    Liu N; Zhong L; Ni G; Lin J; Xie L; Li T; Dan H; Chen Q
    Onco Targets Ther; 2021; 14():4391-4406. PubMed ID: 34408436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of therapeutic targets and prognostic biomarkers of the ephrin receptor subfamily in pancreatic adenocarcinoma.
    Zou J; Zhang K; Zhu J; Tu C; Guo J
    J Int Med Res; 2024 Jan; 52(1):3000605231218559. PubMed ID: 38180878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive multi-omics analysis and prognostic significance of fibroblast growth factor binding protein 1 (FGFBP1) in pancreatic adenocarcinoma.
    Shao Z; Abdel-Maksoud MA; Saleh IA; Al-Hawadi JS; Zomot N; Almutairi SM; Chen J
    Am J Transl Res; 2024; 16(8):4101-4119. PubMed ID: 39262727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PEX13 is a potential immunotherapeutic indicator and prognostic biomarker for various tumors including PAAD.
    Dong P; Du X; Yang T; Li D; Du Y; Wei Y; Sun J
    Oncol Lett; 2023 Dec; 26(6):512. PubMed ID: 37920431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deoxythymidylate kinase (DTYMK) participates in cell cycle arrest to promote pancreatic adenocarcinoma progression regulated by miR-491-5p through TP53 and is associated with tumor immune infiltration.
    Bao W; Yang H; Zhou S; Huang F; Wei Z; Peng Z
    J Gastrointest Oncol; 2023 Jun; 14(3):1546-1559. PubMed ID: 37435228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unraveling the role of Major Vault Protein as a novel immune-related biomarker that promotes the proliferation and migration in pancreatic adenocarcinoma.
    Wu X; Hao L; Lin J; Guo X; Luo Y; Li C
    Front Immunol; 2024; 15():1399222. PubMed ID: 39026679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis and validation of the potential of the MYO1E gene in pancreatic adenocarcinoma based on a bioinformatics approach.
    Liu S; Liu P; Fei X; Zhu C; Hou J; Wang X; Pan Y
    Oncol Lett; 2023 Jul; 26(1):285. PubMed ID: 37274465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis.
    Li J; Lin J; Ji Y; Wang X; Fu D; Wang W; Shen B
    Cell Oncol (Dordr); 2023 Oct; 46(5):1381-1398. PubMed ID: 37138146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNAs-Regulated High Expression of LAMC2 Reveals a Prognostic and Immunological Value in Pancreatic Adenocarcinoma.
    Liu J; Wang M; Wang M; Wang F; Zhang B
    Biochem Genet; 2024 Feb; 62(1):485-503. PubMed ID: 37382751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EIF2Ss, a Novel c-Myc-Correlated Gene Family, is Associated with Poor Prognosis and Immune Infiltration in Pancreatic Adenocarcinoma.
    Cao Z; Jing Y; Cheng C; Wang F; Guan M; Zhang K; Jiao J; Ruan L; Chen Z
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):119. PubMed ID: 38538250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PCDH1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapy.
    Du X; Yi X; Zou X; Chen Y; Tai Y; Ren X; He X
    BMC Cancer; 2023 Nov; 23(1):1102. PubMed ID: 37957639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High WFDC3 gene expression is associated with poor prognosis and reduced immune cells infiltration in pancreatic adenocarcinoma: A study using the TCGA database and bioinformatics analysis.
    Wu W; Wang J; Hu Z; Zhao Y; Wang X; Bai N; Chen L; Gao P
    Medicine (Baltimore); 2023 Oct; 102(42):e35595. PubMed ID: 37861515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The NT5DC family: expression profile and prognostic value in pancreatic adenocarcinoma.
    Yu X; Sun R; Yang X; He X; Guo H; Ou C
    J Cancer; 2023; 14(12):2274-2288. PubMed ID: 37576396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular subtyping based on TRP family and prognostic assessment for TRP-associated lncRNAs in pancreatic adenocarcinoma.
    Li L; Xiao Z; He P; Zou W; Deng Z; Zhang G; Liu R
    BMC Gastroenterol; 2022 Nov; 22(1):454. PubMed ID: 36371178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and validation of a novel anoikis-related long non-coding RNA signature for pancreatic adenocarcinoma to predict the prognosis and immune response.
    Jiang Y; Ye Y; Huang Y; Wu Y; Wang G; Gui Z; Zhang M; Zhang M
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):15069-15083. PubMed ID: 37620430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive Analysis of SMC Gene Family Prognostic Value and Immune Infiltration in Patients With Pancreatic Adenocarcinoma.
    Nie H; Wu Y; Ou C; He X
    Front Med (Lausanne); 2022; 9():832312. PubMed ID: 35372377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioinformatic Analysis of Prognostic Value of Pyroptosis-Related Genes and Its Effect on Immune Cell Infiltration in Pancreatic Adenocarcinoma.
    Wang J; Zhang H; Shao P; Zhang X; Zhou B
    Int J Gen Med; 2022; 15():2311-2319. PubMed ID: 35256857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Values and Clinical Significance of S100 Family Member's Individualized mRNA Expression in Pancreatic Adenocarcinoma.
    Li X; Qiu N; Li Q
    Front Genet; 2021; 12():758725. PubMed ID: 34804125
    [No Abstract]   [Full Text] [Related]  

  • 40. Construction and Validation of an Immune-Based Prognostic Model for Pancreatic Adenocarcinoma Based on Public Databases.
    Mao M; Ling H; Lin Y; Chen Y; Xu B; Zheng R
    Front Genet; 2021; 12():702102. PubMed ID: 34335699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.